These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical Manifestations and Molecular Characterization of Pertactin-Deficient and Pertactin-Producing Bordetella pertussis in Children, Philadelphia 2007-2014. Vodzak J; Queenan AM; Souder E; Evangelista AT; Long SS Clin Infect Dis; 2017 Jan; 64(1):60-66. PubMed ID: 27624959 [TBL] [Abstract][Full Text] [Related]
5. Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Perú, 2012. Bailon H; León-Janampa N; Padilla C; Hozbor D BMC Infect Dis; 2016 Aug; 16():422. PubMed ID: 27530444 [TBL] [Abstract][Full Text] [Related]
7. Genetic Variation of Bordetella pertussis in Austria. Wagner B; Melzer H; Freymüller G; Stumvoll S; Rendi-Wagner P; Paulke-Korinek M; Repa A; Mooi FR; Kollaritsch H; Mittermayer H; Kessler HH; Stanek G; Steinborn R; Duchêne M; Wiedermann U PLoS One; 2015; 10(7):e0132623. PubMed ID: 26182210 [TBL] [Abstract][Full Text] [Related]
8. Pertactin-negative Bordetella pertussis strains in Canada: characterization of a dozen isolates based on a survey of 224 samples collected in different parts of the country over the last 20 years. Tsang RS; Shuel M; Jamieson FB; Drews S; Hoang L; Horsman G; Lefebvre B; Desai S; St-Laurent M Int J Infect Dis; 2014 Nov; 28():65-9. PubMed ID: 25244999 [TBL] [Abstract][Full Text] [Related]
9. Emerging of ptxP3 lineage in Bordetella pertussis strains circulating in a population in northeastern Mexico. Gutiérrez-Ferman JL; Villarreal-Treviño L; Ramírez-Aranda JM; Camacho-Ortiz A; Ballesteros-Elizondo MR; Moreno-Juárez MR; Mendoza-Olazarán S; de la O Cavazos ME; Villarreal-Pérez JZ; Gómez-Govea MA; Garza-González E Epidemiol Infect; 2018 Dec; 146(16):2096-2101. PubMed ID: 30136639 [TBL] [Abstract][Full Text] [Related]
10. The evolving nature of Tsang RSW; Shuel M; Cronin K; Deng S; Whyte K; Marchand-Austin A; Ma J; Bolotin S; Crowcroft N; Schwartz K; Van Domselaar G; Graham M; Jamieson FB Can J Microbiol; 2019 Nov; 65(11):823-830. PubMed ID: 31295416 [TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiology of Bordetella pertussis and analysis of vaccine antigen genes from clinical isolates from Shenzhen, China. Wu S; Hu Q; Yang C; Zhou H; Chen H; Zhang Y; Jiang M; He Y; Shi X Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):53. PubMed ID: 34407803 [TBL] [Abstract][Full Text] [Related]
12. Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012. Zeddeman A; van Gent M; Heuvelman CJ; van der Heide HG; Bart MJ; Advani A; Hallander HO; Wirsing von Konig CH; Riffelman M; Storsaeter J; Vestrheim DF; Dalby T; Krogfelt KA; Fry NK; Barkoff AM; Mertsola J; He Q; Mooi F Euro Surveill; 2014 Aug; 19(33):. PubMed ID: 25166348 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. Pawloski LC; Queenan AM; Cassiday PK; Lynch AS; Harrison MJ; Shang W; Williams MM; Bowden KE; Burgos-Rivera B; Qin X; Messonnier N; Tondella ML Clin Vaccine Immunol; 2014 Feb; 21(2):119-25. PubMed ID: 24256623 [TBL] [Abstract][Full Text] [Related]
14. Pertactin-deficient Bordetella pertussis isolates in Poland-a country with whole-cell pertussis primary vaccination. Polak M; Zasada AA; Mosiej E; Krysztopa-Grzybowska K; Witkowski L; Rzeczkowska M; Piekarska K; Lutyńska A Microbes Infect; 2019; 21(3-4):170-175. PubMed ID: 30580013 [TBL] [Abstract][Full Text] [Related]